Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Malignancies”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Not applicableStudy completedNCT00003611
What this trial is testing

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Who this might be right for
Non-melanomatous Skin Cancer
Alliance for Clinical Trials in Oncology 129
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Post-approval studies (Phase 4)Ended earlyNCT02444936
What this trial is testing

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Who this might be right for
Shingles
Louis Stokes VA Medical Center 22
Early research (Phase 1)Active Not RecruitingNCT03162627
What this trial is testing

Selumetinib and Olaparib in Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital Organs+2 more
M.D. Anderson Cancer Center 90
Not applicableStudy completedNCT00904579
What this trial is testing

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Who this might be right for
Immunocompromised HostOrgan TransplantationCancer
National Cancer Institute (NCI) 19,929,901
Not applicableActive Not RecruitingNCT02991105
What this trial is testing

Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study

Who this might be right for
MalignancyTransplant ComplicationCancer+3 more
University of Birmingham 85,410
Not applicableLooking for participantsNCT05301101
What this trial is testing

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

Who this might be right for
Solid Tumor
Medical College of Wisconsin 120
Not applicableLooking for participantsNCT05284877
What this trial is testing

The Organ Transplant Recipient HPV and Skin Cancer Study

Who this might be right for
Solid Organ Transplant RecipientSkin CancerSkin Dysplasia+4 more
Merete Haedersdal 1,500
Not applicableUnknownNCT05081141
What this trial is testing

HHV8 and Solid Organ Transplantation

Who this might be right for
HHV8HHV8 InfectionHHV8-Related Malignant Neoplasm+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 250
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Early research (Phase 1)Looking for participantsNCT06741072
What this trial is testing

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Who this might be right for
Chronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5EBV-Related Lymphoproliferative Disorder+2 more
Ohio State University Comprehensive Cancer Center 55
Not applicableStudy completedNCT03685539
What this trial is testing

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00064246
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

Who this might be right for
Post-transplant Lymphoproliferative DisorderRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+5 more
National Cancer Institute (NCI) 28
Large-scale testing (Phase 3)Ended earlyNCT01532453
What this trial is testing

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Who this might be right for
Actinic KeratosesSquamous Cell Carcinomas
Spirig Pharma Ltd. 244
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Not applicableNot Yet RecruitingNCT07391046
What this trial is testing

Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients

Who this might be right for
Chronic DiseaseImmunocompromisedHIV Infection+8 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,500
Early research (Phase 1)Study completedNCT00095160
What this trial is testing

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Next Page